Y

Yonghe Medical Group Co Ltd
HKEX:2279

Watchlist Manager
Yonghe Medical Group Co Ltd
HKEX:2279
Watchlist
Price: 1.23 HKD 4.24% Market Closed
Updated: May 19, 2024

EV/EBITDA
Enterprise Value to EBITDA

-1.9
Current
-2.5
Median
13.1
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-1.9
=
Enterprise Value
927.6m
/
EBITDA
-444.6m
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
hidden
2-Years Forward
EV/EBITDA
hidden
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More